PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer and infectious disease. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.
Gobiquity™ (gō-ˈbi-kwə-tē) Mobile Health is committed to prescribed mobile health applications for the early detection and prevention of health disorders and chronic diseases. By using the smartphone as a platform, Gobiquity’s product line allows for greater accessibility and ease of use that will transfer to increased compliance and ultimately change lives. Gobiquity has several mobile health vision screening applications in development, the first of which will test for eye disorders in infants and children.